JONATHAN FELLERS: Open Payments
NPI 1508091281 · PORTLAND, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,274 in 120 payments from 15 companies in 2025. Trend: 2023 $1,720 · 2024 $1,932 · 2025 $2,274
Food & beverage: $2,274
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 20 | $322 |
| Alkermes, Inc. | 12 | $270 |
| Teva Pharmaceuticals USA, Inc. | 19 | $232 |
| Lundbeck LLC | 7 | $189 |
| Otsuka America Pharmaceutical, Inc. | 8 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $183 |
| ABBVIE INC. | 6 | $165 |
| Janssen Pharmaceuticals, Inc | 8 | $147 |
| Collegium Pharmaceutical, Inc. | 7 | $144 |
| Indivior Inc. | 7 | $142 |
Products named: REXULTI, Auvelity, UZEDY, ARISTADA, CAPLYTA, VRAYLAR, SPRAVATO, Jornay PM.
Industry payments across ME — which companies pay providers there.
